Nasdaq · CIK 0001849296
OKYO OKYO Pharma Ltd
Insider trading from SEC Form 4. Last filing Jun 10, 2026.
OKYO Pharma Ltd (OKYO) has 5 SEC Form 4 filings on file from 5 insiders, the latest filed on Jun 10, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at OKYO Pharma Ltd, scored.
Transactions
Every row filed, 5 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | John P Brancaccio director | AGrant or award Optionderivative | +6,500 | $1.85 | $12k | 138,394 | Jun 10, 2026 |
| Jun 8, 2026 | Gabriele M Cerrone director, owner | AGrant or award COMMON STOCKindirect: Via Panetta Partners Limited | +300,000 | $1.72 | $516k | 10,826,416 | Jun 10, 2026 |
| Jun 8, 2026 | Bernard Denoyer director | AGrant or award Optionderivative | +3,500 | $1.85 | $6,475 | 35,190 | Jun 10, 2026 |
| Jun 8, 2026 | Keeren Rameshchandra Shah Chief Financial Officer | AGrant or award Optionderivative | +40,000 | $1.85 | $74k | 544,819 | Jun 10, 2026 |
| Jun 8, 2026 | Willy Jules Simon director | AGrant or award Optionderivative | +6,500 | $1.85 | $12k | 135,502 | Jun 10, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- John P Brancacciodirector
- Gabriele M Cerronedirector, owner
- Bernard Denoyerdirector
- Keeren Rameshchandra ShahChief Financial Officer
- Willy Jules Simondirector
Questions about OKYO
Answered from the filings on this page, as of the latest one.
Are insiders buying OKYO?
No. In the last 90 days no insider at OKYO Pharma Ltd bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade OKYO on the open market?
No open-market trade has been scored at OKYO Pharma Ltd. The latest Form 4 on file was filed on Jun 10, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at OKYO Pharma Ltd?
5 people have filed a Form 4 at OKYO Pharma Ltd, among them John P Brancaccio (director), Gabriele M Cerrone (director and 10% owner), Bernard Denoyer (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.